logo

For the Inventor, By the Inventor

Kanagawa, Japan

Kohei Takeuchi

This inventor holds 16 USPTO granted patents and 6 published patent applications and 8 EPO patents, primarily in Heterocyclic Compounds. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2019-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kohei Takeuchi. Retrieved from https://idiyas.com/inventor/kohei-takeuchi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 16 

% Patents Active = 87.5

 

Average Co-Inventor Count = 12.5

ph-index = 4

Forward Citations = 58(Granted Patents)


Company Filing History:

goldMedal16 out of 1,229 
 
Takeda Pharmaceutical Company Limited
 patents

Years Active: 2019-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
Heterocyclic Compounds
Macrocyclic Compounds
Pyrrolo Derivatives
Orexin Receptor Agonists
Sulfonamide Derivatives
Pyrrolidine Compounds
Excessive Sleepiness
Cataplexy Treatments
Pharmaceutical Applications
Chemical Compounds
Receptor Agonists
16 patents (USPTO):Explore Patents
1. 12767667 - Macrocyclic heterocycle compounds and use thereof (2026-10-20),
2. 12662453 - Heterocyclic compound and use thereof (2026-06-23),
3. 12534471 - Pyrrolo[1, 2-c]imidazole derivatives as orexin type 2 receptor agonists and methods of use thereof (2026-01-27),
4. 12421188 - Heterocyclic compound and use thereof (2025-09-23),
5. 12415782 - Heterocyclic compound and use thereof (2025-09-16),
6. 12404237 - Method of treating excessive sleepiness and/or cataplexy using n-{2-(([1,1'-biphenyl]-3-yl)methyl)pyrrolidin-3-yl}sulfonamide derivatives (2025-09-02),
7. 12091410 - Heterocyclic compound (2024-09-17),
8. 12071434 - Heterocyclic compound (2024-08-27),
9. 11987586 - Pyrrolo[1,2-c]imidazole derivatives as orexin type 2 receptor agonists (2024-05-21),
10. 11655241 - Heterocyclic compound and use thereof (2023-05-23),
11. 11440883 - Heterocyclic compound and use thereof (2022-09-13),
12. 11319286 - Heterocyclic compound and application thereof (2022-05-03),
13. 11059780 - Substituted pyrrolidine compound and use thereof (2021-07-13),
14. 11034700 - Substituted pyrrolidine compound and use thereof (2021-06-15),
15. 10584097 - Heterocyclic compound and use thereof (2020-03-10),

Title: Unveiling the Innovative Inventor: Kohei Takeuchi

Introduction:

In the realm of groundbreaking patents in the field of pharmaceuticals, Kohei Takeuchi stands out as a visionary inventor. Residing in Kanagawa, Japan, Takeuchi is renowned for his exceptional contributions to the domain of medicinal chemistry. With an impressive track record of 7 patents to his name, his inventive spirit knows no bounds.

Latest Patents:

Among his latest patents, Takeuchi has pioneered a remarkable heterocyclic compound and its applications. The patent focuses on a compound with orexin type 2 receptor agonist activity, offering promising implications for the prophylaxis and treatment of narcolepsy. This revolutionary discovery is encapsulated in a compound represented by the formula (I).

Career Highlights:

Takeuchi's professional journey is intricately linked with the reputable Takeda Pharmaceutical Company Limited. Within this esteemed organization, he has channelled his expertise to drive innovation and redefine the boundaries of pharmaceutical advancements. His relentless pursuit of excellence has positioned him as a trailblazer in the pharmaceutical industry.

Collaborations:

Collaboration plays a pivotal role in Takeuchi's innovative endeavors. His notable coworkers, Yuichi Kajita and Yuhei Miyanohana, have been instrumental in shaping his inventive pursuits. Through collaborative efforts and collective ingenuity, the team has harnessed synergies to unlock new frontiers in pharmaceutical research and development.

Conclusion:

In conclusion, Kohei Takeuchi emerges as a beacon of creativity and dedication in the realm of pharmaceutical inventions. His exceptional patents, coupled with his strategic collaborations and pivotal role at Takeda Pharmaceutical Company Limited, underscore his indelible impact on the landscape of medicinal chemistry. As a visionary inventor, Takeuchi continues to inspire and pave the way for transformative breakthroughs in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…